Profile
Daniel G.
Marquess worked as a Research Scientist at GSK Plc from 1994 to 1998.
He then worked as Vice President-Medicinal Chemistry at Innoviva, Inc. After that, he worked as Vice President & Head-Medicinal Chemistry at Theravance Biopharma, Inc. from 1998 to 2015.
Finally, he worked as Chief Scientific Officer at Unity Biotechnology, Inc. from 2015 to 2021.
Marquess holds a doctorate from the University of Oxford and an undergraduate degree from Queen's University of Belfast.
Former positions of Daniel G. Marquess
| Companies | Position | End |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01/12/2015 |
| GSK PLC | Corporate Officer/Principal | 01/01/1998 |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
Training of Daniel G. Marquess
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innoviva, Inc.
Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Queen's University of Belfast
Queen's University of Belfast Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Unity Biotechnology, Inc.
Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
- Stock Market
- Insiders
- Daniel G. Marquess
















